189 related articles for article (PubMed ID: 33464704)
1. Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome.
Uguagliati B; Al-Absi AR; Stagni F; Emili M; Giacomini A; Guidi S; Nyengaard JR; Bartesaghi R
Hippocampus; 2021 Apr; 31(4):435-447. PubMed ID: 33464704
[TBL] [Abstract][Full Text] [Related]
2. Early Appearance of Dendritic Alterations in Neocortical Pyramidal Neurons of the Ts65Dn Model of Down Syndrome.
Uguagliati B; Stagni F; Emili M; Giacomini A; Russo C; Guidi S; Bartesaghi R
Dev Neurosci; 2022; 44(1):23-38. PubMed ID: 34852343
[TBL] [Abstract][Full Text] [Related]
3. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.
Giacomini A; Stagni F; Emili M; Guidi S; Salvalai ME; Grilli M; Vidal-Sanchez V; Martinez-Cué C; Bartesaghi R
Brain Res Bull; 2018 Jun; 140():378-391. PubMed ID: 29935232
[TBL] [Abstract][Full Text] [Related]
4. Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome.
Emili M; Stagni F; Salvalai ME; Uguagliati B; Giacomini A; Albac C; Potier MC; Grilli M; Bartesaghi R; Guidi S
Neurobiol Dis; 2020 Jul; 140():104874. PubMed ID: 32325119
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
[TBL] [Abstract][Full Text] [Related]
6. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome.
Stagni F; Magistretti J; Guidi S; Ciani E; Mangano C; Calzà L; Bartesaghi R
PLoS One; 2013; 8(4):e61689. PubMed ID: 23620781
[TBL] [Abstract][Full Text] [Related]
8. Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome.
Stagni F; Salvalai ME; Giacomini A; Emili M; Uguagliati B; Xia E; Grilli M; Bartesaghi R; Guidi S
Neurobiol Dis; 2019 Sep; 129():44-55. PubMed ID: 31085229
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Stagni F; Raspanti A; Giacomini A; Guidi S; Emili M; Ciani E; Giuliani A; Bighinati A; Calzà L; Magistretti J; Bartesaghi R
Neurobiol Dis; 2017 Jul; 103():11-23. PubMed ID: 28359846
[TBL] [Abstract][Full Text] [Related]
10. Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndrome.
Guidi S; Stagni F; Bianchi P; Ciani E; Ragazzi E; Trazzi S; Grossi G; Mangano C; Calzà L; Bartesaghi R
Brain Pathol; 2013 Mar; 23(2):129-43. PubMed ID: 22817700
[TBL] [Abstract][Full Text] [Related]
11. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
[TBL] [Abstract][Full Text] [Related]
12. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome.
Bianchi P; Ciani E; Guidi S; Trazzi S; Felice D; Grossi G; Fernandez M; Giuliani A; Calzà L; Bartesaghi R
J Neurosci; 2010 Jun; 30(26):8769-79. PubMed ID: 20592198
[TBL] [Abstract][Full Text] [Related]
13. Early chronic fasudil treatment rescues hippocampal alterations in the Ts65Dn model for down syndrome.
López-Hidalgo R; Ballestín R; Lorenzo L; Sánchez-Martí S; Blasco-Ibáñez JM; Crespo C; Nacher J; Varea E
Neurochem Int; 2024 Mar; 174():105679. PubMed ID: 38309665
[TBL] [Abstract][Full Text] [Related]
14. The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome.
Stagni F; Uguagliati B; Emili M; Giacomini A; Bartesaghi R; Guidi S
Sci Rep; 2021 Mar; 11(1):6300. PubMed ID: 33737521
[TBL] [Abstract][Full Text] [Related]
15. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R
Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735
[TBL] [Abstract][Full Text] [Related]
17. Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome.
Bianchi P; Bettini S; Guidi S; Ciani E; Trazzi S; Stagni F; Ragazzi E; Franceschini V; Bartesaghi R
Exp Neurol; 2014 Jan; 251():1-11. PubMed ID: 24192151
[TBL] [Abstract][Full Text] [Related]
18. Subicular hypotrophy in fetuses with Down syndrome and in the Ts65Dn model of Down syndrome.
Stagni F; Giacomini A; Emili M; Uguagliati B; Bonasoni MP; Bartesaghi R; Guidi S
Brain Pathol; 2019 May; 29(3):366-379. PubMed ID: 30325080
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice.
Contestabile A; Fila T; Ceccarelli C; Bonasoni P; Bonapace L; Santini D; Bartesaghi R; Ciani E
Hippocampus; 2007; 17(8):665-78. PubMed ID: 17546680
[TBL] [Abstract][Full Text] [Related]
20. Morphological alterations in the hippocampus of the Ts65Dn mouse model for Down Syndrome correlate with structural plasticity markers.
Villarroya O; Ballestín R; López-Hidalgo R; Mulet M; Blasco-Ibáñez JM; Crespo C; Nacher J; Gilabert-Juan J; Varea E
Histol Histopathol; 2018 Jan; 33(1):101-115. PubMed ID: 28374408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
